Perspective Therapeutics Inc (CATX)

Überblick Nachrichten Preisverlauf Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Perspective Therapeutics Inc Stock (CATX) Company Profile

Perspective Therapeutics Inc

Healthcare (1176)

Medical Devices (162)

509-375-1202

350 Hills Street, Suite 106, Richland

Nächster Verdiensttermin

Neueste SEC-Einreichungen

CATX's Discussions on Twitter

Vergleichen Sie CATX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CATX Perspective Therapeutics Inc	3.52	237.91M	6.96M	-46.51M	-37.99M	-0.1716
ABT Abbott Laboratories	116.79	201.01B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	395.85	150.90B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	100.91	148.72B	15.91B	1.79B	1.89B	1.21
MDT Medtronic Plc	88.38	113.33B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	69.97	41.27B	6.60B	4.16B	490.10M	6.93

Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-11-25	Herabstufung	BofA Securities	Buy → Neutral
2024-10-24	Eingeleitet	UBS	Buy
2024-10-01	Eingeleitet	Wedbush	Outperform
2024-09-25	Eingeleitet	Truist	Buy
2024-07-25	Eingeleitet	BofA Securities	Buy
2024-05-09	Eingeleitet	Cantor Fitzgerald	Overweight

Alle ansehen

Perspective Therapeutics Inc Aktie (CATX) Neueste Nachrichten

Finanzdaten der Perspective Therapeutics Inc-Aktie (CATX)

Perspective Therapeutics Inc (CATX)

Perspective Therapeutics Inc Stock (CATX) Company Profile

Vergleichen Sie CATX mit anderen Aktien

Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades

Perspective Therapeutics Inc Aktie (CATX) Neueste Nachrichten

Perspective Therapeutics, Inc. (NYSE:CATX) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Perspective Therapeutics, Inc. (NYSE:CATX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Perspective Therapeutics’ (CATX) “Outperform” Rating Reiterated at Royal Bank of Canada - Defense World

Financial Survey: Beyond Air (NASDAQ:XAIR) versus Perspective Therapeutics (NYSE:CATX) - Defense World

Perspective Therapeutics' (CATX) "Outperform" Rating Reiterated at Royal Bank of Canada - MarketBeat

Perspective Therapeutics provides business updates, strategic priorities - Yahoo Finance

Perspective Therapeutics (NYSE:CATX) Receives Outperform Rating from Wedbush - Defense World

Perspective Therapeutics (NYSE:CATX) Receives "Outperform" Rating from Wedbush - MarketBeat

Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Perspective Therapeutics Advances Cancer Pipeline with $227.8M Cash Runway Through 2026 - StockTitan

Barclays PLC Has $1.52 Million Stock Position in Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

Pre-market Movers: AVGR, TIVC, ATNF, SLGL... - RTTNews

Neumora Therapeutics Inc (NMRA): A New Perspective - Stocks Register

Perspective Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Perspective Therapeutics CEO to Present at JP Morgan Healthcare Conference and Biotech Showcase - StockTitan

Perspective Therapeutics, Inc. (NYSE:CATX) Shares Sold by Jane Street Group LLC - Defense World

Perspective Therapeutics Appoints New Chief Financial Officer - TipRanks

Perspective Therapeutics Announces Chief Financial Officer Changes - Marketscreener.com

Perspective Therapeutics Names Juan Graham as Finance Chief - MarketWatch

Perspective Therapeutics Appoints Juan Graham, MBA as Chief Financial Officer - The Manila Times

Perspective Therapeutics Appoints FibroGen Veteran Juan Graham as New CFO to Drive Growth Strategy - StockTitan

Perspective Therapeutics Inc (AMEX: CATX) Could Fell Another -684.31% - Stocks Register

Geode Capital Management LLC Has $15.55 Million Position in Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

Barclays PLC Grows Stock Holdings in Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

Perspective Therapeutics, Inc. (NYSE:CATX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Bullish On Perspective Therapeutics: Early Successes And Large Oncology TAM - Seeking Alpha

Perspective Therapeutics, Inc.(NYSEAM:CATX) dropped from S&P Biotechnology Select Industry Index - Marketscreener.com

State Street Corp Grows Position in Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

Perspective Therapeutics, Inc. (NYSE:CATX) Shares Acquired by State Street Corp - MarketBeat

Minerva Surgical (NASDAQ:UTRS) versus Perspective Therapeutics (NYSE:CATX) Financial Contrast - Defense World

Perspective Therapeutics: Definitely Not Looking Overvalued Now - Seeking Alpha

Pliant Therapeutics Inc (PLRX): A New Perspective - Stocks Register

Neuroendocrine Tumor Market to Reach New Heights in Growth by 2034, DelveInsight Predicts - NEWS CHANNEL NEBRASKA

Perspective Therapeutics (NYSE:CATX) vs. NeuroPace (NASDAQ:NPCE) Head to Head Contrast - Defense World

Targeted Alpha Therapy Market, Drugs Approval, Proprietary Technologies & Clinical Trials: 20+ Drugs of Targeted Alpha Therapy In Clinical Trials - GlobeNewswire Inc.

Perspective Therapeutics' SWOT analysis: radiopharmaceutical stock faces pivotal moment - Investing.com

BNP Paribas Financial Markets Buys 44,174 Shares of Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

Charles Schwab Investment Management Inc. Acquires 298,778 Shares of Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

Perspective Therapeutics, Inc. (NYSE:CATX) Shares Acquired by Charles Schwab Investment Management Inc. - MarketBeat

Walleye Capital LLC Sells 494,706 Shares of Perspective Therapeutics, Inc. (NYSE:CATX) - MarketBeat

Perspective Therapeutics, Inc. (NYSE:CATX) Director Acquires $100,003.75 in Stock - MarketBeat

Janus Henderson Group PLC Has $64.01 Million Stake in Perspective Therapeutics, Inc. (NYSE:CATX) - MarketBeat

Fmr LLC Purchases 5,370,392 Shares of Perspective Therapeutics, Inc. (NYSE:CATX) - MarketBeat

Perspective Therapeutics CEO Johan Spoor buys $30,132 in stock By Investing.com - Investing.com Canada

Perspective Therapeutics CEO Johan Spoor buys $30,132 in stock - Investing.com India

Perspective Therapeutics, Inc. (NYSE:CATX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Perspective Therapeutics CFO Jonathan Hunt acquires $48,974 in stock - Investing.com India

Perspective Therapeutics CFO Jonathan Hunt acquires $48,974 in stock By Investing.com - Investing.com Nigeria

Perspective Therapeutics selloff a buying opportunity, says JonesResearch - MSN

Insider Buying: Jonathan Hunt Acquires Shares of Perspective The - GuruFocus.com

Perspective Therapeutics director Robert Williamson acquires shares worth $22,813 - Investing.com

Finanzdaten der Perspective Therapeutics Inc-Aktie (CATX)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie CATX